Benjamin L. Palleiko - 06 Jun 2025 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Benjamin L. Palleiko
Issuer symbol
KALV
Transactions as of
06 Jun 2025
Net transactions value
-$103,950
Form type
4
Filing time
10 Jun 2025, 17:00:45 UTC
Previous filing
23 May 2025
Next filing
10 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Palleiko Benjamin L CHIEF EXECUTIVE OFFICER, Director C/O KALVISTA PHARMACEUTICALS, INC., 55 CAMBRIDGE PARKWAY, SUITE 901E, CAMBRIDGE /s/ Benjamin L. Palleiko 10 Jun 2025 0001366244

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALV Common Stock Options Exercise +15,625 +5.1% 322,243 06 Jun 2025 Direct F1
transaction KALV Common Stock Sale $103,950 -7,169 -2.2% $14.50 315,074 09 Jun 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Restricted Stock Unit Options Exercise $0 -15,625 -8.3% $0.000000 171,876 06 Jun 2025 Common Stock 15,625 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on June 6, 2024, subject to continued service through each vesting date.